Correlation Between Merck and VEON
Can any of the company-specific risk be diversified away by investing in both Merck and VEON at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and VEON into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and VEON, you can compare the effects of market volatilities on Merck and VEON and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of VEON. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and VEON.
Diversification Opportunities for Merck and VEON
Pay attention - limited upside
The 3 months correlation between Merck and VEON is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and VEON in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VEON and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with VEON. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VEON has no effect on the direction of Merck i.e., Merck and VEON go up and down completely randomly.
Pair Corralation between Merck and VEON
Considering the 90-day investment horizon Merck Company is expected to under-perform the VEON. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 1.72 times less risky than VEON. The stock trades about -0.01 of its potential returns per unit of risk. The VEON is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 3,074 in VEON on August 30, 2024 and sell it today you would earn a total of 141.00 from holding VEON or generate 4.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Merck Company vs. VEON
Performance |
| Timeline |
| Merck Company |
| VEON |
Merck and VEON Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and VEON
The main advantage of trading using opposite Merck and VEON positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, VEON can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VEON will offset losses from the drop in VEON's long position.| Merck vs. Emergent Biosolutions | Merck vs. Bausch Health Companies | Merck vs. Neurocrine Biosciences | Merck vs. Teva Pharma Industries |
| VEON vs. Shenandoah Telecommunications Co | VEON vs. Liberty Broadband Corp | VEON vs. Ooma Inc | VEON vs. IDT Corporation |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |